Skip to main content

Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for dyslipidemia in relation to height for total subjects, stratified by BMI status

From: Height correlates with dyslipidemia in non-overweight middle-aged Japanese men

 

Height quartiles

p for trend

1 SD increment of height (5.7 cm)

Q1 (low)

Q2

Q3

Q4 (high)

Total subjects

 No. of paticipants

750

753

752

761

  

 No. of cases (%)

426 (56.8)

392 (52.1)

395 (52.5)

375 (49.3)

  

 Age-adjusted ORs

1.00

0.86 (0.70, 1.05)

0.89 (0.73, 1.09)

0.80 (0.65, 0.98)

0.055

0.95 (0.88, 1.02)

 Multivariable ORs

1.00

0.84 (0.68, 1.04)

0.86 (0.69, 1.07)

0.78 (0.62, 0.97)

0.040

0.94 (0.87, 1.01)

BMI < 25 kg/m2

 No. of paticipants

485

489

483

495

  

 No. of cases (%)

237 (48.9)

221 (45.2)

199 (41.2)

192 (38.8)

  

 Age-adjusted ORs

1.00

0.91 (0.71, 1.17)

0.79 (0.61, 1.02)

0.74 (0.57, 0.95)

0.011

0.91 (0.83, 0.99)

 Multivariable ORs

1.00

0.86 (0.66, 1.12)

0.75 (0.57, 0.98)

0.72 (0.55, 0.95)

0.011

0.90 (0.82, 0.99)

BMI ≥ 25 kg/m2

 No. of paticipants

265

264

269

266

  

 No. of cases (%)

189 (71.3)

171 (64.8)

196 (72.9)

183 (68.8)

  

 Age-adjusted ORs

1.00

0.75 (0.52, 1.08)

1.10 (0.75, 1.61)

0.91 (0.62, 1.32)

0.865

1.02 (0.89, 1.16)

 Multivariable ORs

1.00

0.77 (0.53, 1.12)

1.11 (0.75, 1.63)

0.91 (0.62, 1.34)

0.860

1.02 (0.89, 1.17)

  1. Dyslipidemia is defined as TG ≥ 150 mg/dL and/or LDL-choresterol ≥ 140 mg/dL, and/or HDL-cholesterol < 40 mg/dL, and/or lipid lowering medication use. Multivariable ORs adjusted further for age, systolic blood pressure, antihypertensive medication use, body mass index, smoking status, alcohol consumption, blood sugar, glucose lowering medication use, and serum creatinine. Height quartiles are <166.7 cm for Q1, 166.7–170.3 cm for Q2, 170.4–174.2 cm for Q3, >174.2 cm for Q4